Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2001 1
2002 4
2003 3
2004 2
2005 9
2006 8
2009 1
2010 1
2011 4
2012 5
2013 4
2014 6
2015 10
2016 10
2017 5
2018 5
2019 7
2020 8
2021 15
2022 8
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
Karlsson Q, Brook MN, Dadaev T, Wakerell S, Saunders EJ, Muir K, Neal DE, Giles GG, MacInnis RJ, Thibodeau SN, McDonnell SK, Cannon-Albright L, Teixeira MR, Paulo P, Cardoso M, Huff C, Li D, Yao Y, Scheet P, Permuth JB, Stanford JL, Dai JY, Ostrander EA, Cussenot O, Cancel-Tassin G, Hoegel J, Herkommer K, Schleutker J, Tammela TLJ, Rathinakannan V, Sipeky C, Wiklund F, Grönberg H, Aly M, Isaacs WB, Dickinson JL, FitzGerald LM, Chua MLK, Nguyen-Dumont T; PRACTICAL Consortium; Schaid DJ, Southey MC, Eeles RA, Kote-Jarai Z. Karlsson Q, et al. Among authors: herkommer k. Eur Urol Oncol. 2021 Aug;4(4):570-579. doi: 10.1016/j.euo.2020.12.001. Epub 2021 Jan 9. Eur Urol Oncol. 2021. PMID: 33436325 Free PMC article.
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.
Krilaviciute A, Becker N, Lakes J, Radtke JP, Kuczyk M, Peters I, Harke NN, Debus J, Koerber SA, Herkommer K, Gschwend JE, Meissner VH, Benner A, Seibold P, Kristiansen G, Hadaschik B, Arsov C, Schimmöller L, Giesel FL, Antoch G, Makowski M, Wacker F, Schlemmer HP, Kaaks R, Albers P. Krilaviciute A, et al. Among authors: herkommer k. Eur Urol Oncol. 2023 Dec;6(6):566-573. doi: 10.1016/j.euo.2023.09.008. Epub 2023 Oct 6. Eur Urol Oncol. 2023. PMID: 37806841
[Familial prostate cancer and genetic predisposition].
Meissner VH, Jahnen M, Herkommer K. Meissner VH, et al. Among authors: herkommer k. Urologe A. 2021 May;60(5):567-575. doi: 10.1007/s00120-021-01491-y. Epub 2021 Mar 15. Urologe A. 2021. PMID: 33721089 Review. German.
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial.
Krilaviciute A, Albers P, Lakes J, Radtke JP, Herkommer K, Gschwend J, Peters I, Kuczyk M, Koerber SA, Debus J, Kristiansen G, Schimmöller L, Antoch G, Makowski M, Wacker F, Schlemmer H, Benner A, Giesel F, Siener R, Arsov C, Hadaschik B, Becker N, Kaaks R. Krilaviciute A, et al. Among authors: herkommer k. Int J Cancer. 2023 Mar 1;152(5):854-864. doi: 10.1002/ijc.34295. Epub 2022 Oct 5. Int J Cancer. 2023. PMID: 36121664 Free article. Clinical Trial.
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M, Albers P, Schlemmer HP, Hellms S, Bonekamp D, Sauter A, Hadaschik B, Krilaviciute A, Radtke JP, Seibold P, Lakes J, Arsov C, Gschwend JE, Herkommer K, Makowski M, Kuczyk MA, Wacker F, Harke N, Debus J, Körber SA, Benner A, Kristiansen G, Giesel FL, Antoch G, Kaaks R, Becker N, Schimmöller L. Boschheidgen M, et al. Among authors: herkommer k. Eur Urol. 2024 Feb;85(2):105-111. doi: 10.1016/j.eururo.2023.09.027. Epub 2023 Oct 18. Eur Urol. 2024. PMID: 37863727
[What causes prostate cancer: patient-perceived causes].
Goethe VE, Dinkel A, Schulwitz H, Nöhreiter A, Gschwend JE, Herkommer K. Goethe VE, et al. Among authors: herkommer k. Aktuelle Urol. 2021 Apr;52(2):136-142. doi: 10.1055/a-1005-6273. Epub 2019 Oct 8. Aktuelle Urol. 2021. PMID: 31594005 German.
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.
Arsov C, Becker N, Hadaschik BA, Hohenfellner M, Herkommer K, Gschwend JE, Imkamp F, Kuczyk MA, Antoch G, Kristiansen G, Siener R, Semjonow A, Hamdy FC, Lilja H, Vickers AJ, Schröder FH, Albers P. Arsov C, et al. Among authors: herkommer k. Eur Urol. 2013 Dec;64(6):873-5. doi: 10.1016/j.eururo.2013.05.022. Epub 2013 May 14. Eur Urol. 2013. PMID: 23707067 Clinical Trial. No abstract available.
Benefit finding in long-term prostate cancer survivors.
Lassmann I, Dinkel A, Marten-Mittag B, Jahnen M, Schulwitz H, Gschwend JE, Herkommer K. Lassmann I, et al. Among authors: herkommer k. Support Care Cancer. 2021 Aug;29(8):4451-4460. doi: 10.1007/s00520-020-05971-3. Epub 2021 Jan 15. Support Care Cancer. 2021. PMID: 33447865 Free PMC article.
Changing diagnostic and therapeutic concepts in high-flow priapism.
Kuefer R, Bartsch G Jr, Herkommer K, Krämer SC, Kleinschmidt K, Volkmer BG. Kuefer R, et al. Among authors: herkommer k. Int J Impot Res. 2005 Mar-Apr;17(2):109-13. doi: 10.1038/sj.ijir.3901257. Int J Impot Res. 2005. PMID: 15229624 Review.
109 results